Page last updated: 2024-10-21

5,8,11,14-eicosatetraynoic acid and Glioblastoma

5,8,11,14-eicosatetraynoic acid has been researched along with Glioblastoma in 1 studies

5,8,11,14-Eicosatetraynoic Acid: A 20-carbon unsaturated fatty acid containing 4 alkyne bonds. It inhibits the enzymatic conversion of arachidonic acid to prostaglandins E(2) and F(2a).

Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, KM1
Petrik, D1
Mullane, K1
Harris, JE1

Other Studies

1 other study available for 5,8,11,14-eicosatetraynoic acid and Glioblastoma

ArticleYear
Spontaneous chemiluminescence of ETYA (5,8,11,14-eicosatetraynoic acid) is inhibited by catalase or peroxidase.
    Prostaglandins, leukotrienes, and essential fatty acids, 1994, Volume: 51, Issue:4

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Arachidonic Acid; Catalase; Free Radicals; Glioblastoma; Humans; Lu

1994